Catalyst Wire Dossier Catalyst Wire Dossier

Idursulfase-beta

idursulfase-beta · Green Cross Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Idursulfase-beta, covering 2014-06-20 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of Idursulfase-beta (GC1111) in Hunter Syndrome [Phase 2]

See pricing